Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Nov 15;132(22):e165287.
doi: 10.1172/JCI165287.

Does treating with anti-PD-1 to improve glomerular health come without a cost? Reply

Stuart J Shankland  1 , Jeffrey W Pippin  1 , Oliver Wessely  2
Affiliations
Comment

Does treating with anti-PD-1 to improve glomerular health come without a cost? Reply

Stuart J Shankland et al. J Clin Invest. .
No abstract available

Keywords: Aging; Drug therapy.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: The authors have declared that no conflict of interest exists.

Comment on

References

    1. Jhaveri KD, Kitchlu A, Abudayyeh A. Does treating with anti–PD-1 to improve glomerular health come without a cost? J Clin Invest. 2022;132(22):e164747. - PMC - PubMed
    1. Pippin JW, et al. Upregulated PD-1 signaling antagonizes glomerular health in aged kidneys and disease. J Clin Invest. 2022;132(16):e156250. doi: 10.1172/JCI156250. - DOI - PMC - PubMed
    1. Kitchlu A, et al. A systematic review of immune checkpoint inhibitor-associated glomerular disease. Kidney Int Rep. 2021;6(1):66–77. doi: 10.1016/j.ekir.2020.10.002. - DOI - PMC - PubMed
    1. Wanchoo R, et al. Adverse renal effects of immune checkpoint inhibitors: a narrative review. Am J Nephrol. 2017;45(2):160–169. doi: 10.1159/000455014. - DOI - PubMed
    1. Buchbinder EI, Desai A. CTLA-4 and PD-1 pathways: similarities, differences, and implications of their inhibition. Am J Clin Oncol. 2016;39(1):98–106. doi: 10.1097/COC.0000000000000239. - DOI - PMC - PubMed

MeSH terms

Substances